RB
About
Medical device executive and former V.P. of R&D for C.R. Bard with 28 years of product development and commercialization experience Responsible for development, clinical testing and launch of many medical devices, including the Agento® I.C. anti-infective ETT 17 issued patents plus several pending applications
Position in the VCSift Database
- • 263 investors hold the COO role in VCSift. Ronald Bracken is one of them.
- • 180 investors are based in Columbus, Ohio, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Columbus, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Ronald
Search Investors